久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Pfizer bags USFDA approval for Besponsa biospectrumasia
    August 22, 2017
    The regulatory agency approved the Besponsa, drug fro the treatment of leukemia, under Priority Review and Breakthrough Therapy status
  • EC approves Pfizer’s acute lymphoblastic leukemia treatment Besponsa pharmaceutical-technology
    July 05, 2017
    The European Commission (EC) has approved Pfizer’s Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukaemia (ALL) in the European Union (EU).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service